<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Iodoquinol (United States and Canada: Not available): Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Iodoquinol (United States and Canada: Not available): Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Iodoquinol (United States and Canada: Not available): Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="11973" href="/d/html/11973.html" rel="external">see "Iodoquinol (United States and Canada: Not available): Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="13386" href="/d/html/13386.html" rel="external">see "Iodoquinol (United States and Canada: Not available): Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F183810"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Quinja [DSC]</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F183825"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Amebicide</li></ul></div>
<div class="block doa drugH1Div" id="F183812"><span class="drugH1">Dosing: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Quinja has been discontinued in the United States for more than 1 year.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="1a5eab12-f12a-4079-8d9b-3c3b902004ca">Dermatologic conditions</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Dermatologic conditions:</b>
<b>Topical:</b> Apply to affected area 3 to 4 times daily or as directed.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50991804"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F50989080"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doe drugH1Div" id="F183813"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Topical: Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F183821"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="13386" href="/d/html/13386.html" rel="external">see "Iodoquinol (United States and Canada: Not available): Pediatric drug information"</a>)</p>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Quinja has been discontinued in the United States for more than 1 year.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="db00c349-e8c7-4629-a65f-c9656671bb40">Dermatoses</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Dermatoses: </b>Children ≥12 years and Adolescents: Topical: Apply to affected area(s) 3 to 4 times daily; <b>Note: </b>Due to potential toxicity (neuritis and optical atrophy) and effective alternative therapy, experts recommend against use (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-2146587']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-2146587'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51113912"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block dohp drugH1Div" id="F51113913"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block adr drugH1Div" id="F183787"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">There are no adverse reactions listed in the manufacturer’s labeling for the topical product.</p></div>
<div class="block coi drugH1Div" id="F183800"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to iodoquinol or any component of the formulation</p></div>
<div class="block war drugH1Div" id="F183784"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Hypersensitivity reactions: Discontinue use if hypersensitivity reactions occur.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Thyroid disease: Use with caution in patients with thyroid abnormalities. Thyroid function tests should not be performed for at least one month after discontinuing topical iodoquinol therapy.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Topical: For external use only. May cause discoloration of skin, hair and fabrics; can be removed with normal cleansing and laundry. Not intended for use on infants or under diapers or occlusive dressings. Prolonged use may result in overgrowth of nonsusceptible organisms.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878501"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Oral and topical halogenated hydroxyquinolines including iodoquinol are associated with serious, permanent neuropathy including optic atrophy, the most common neuropathy reported in children. The toxicity seems to be related to the dose and duration of therapy. Large, single doses have been associated with cerebral dysfunction, including disorientation and retrograde amnesia; prolonged therapy (&gt;3 weeks) has been associated with peripheral neuropathy and optic atrophy (AAP 1974). Topical application may lead to significant systemic absorption causing toxicity. Since topical application may lead to toxicity especially in infants and children and alternative effective treatments exist, experts recommend against use (AAP 1990).</p>
<p style="text-indent:0em;margin-top:2em;">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures, and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>
<div class="block prod-avail drugH1Div" id="F52989799"><span class="drugH1">Product Availability</span>
<p style="text-indent:0em;display:inline">Quinja has been discontinued in the United States for &gt;1 year.</p></div>
<div class="block foc drugH1Div" id="F183795"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gel, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Quinja: 1.25% (60 g [DSC]) [contains benzyl alcohol, fd&amp;c blue #1 (brilliant blue), propylene glycol, quinoline yellow (d&amp;c yellow #10), sd alcohol 40b, trolamine (triethanolamine)]</p></div>
<div class="block geq drugH1Div" id="F183780"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">No</p></div>
<div class="block fee drugH1Div" id="F16323202"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Quinja External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1.25-1% (per gram): $159.36</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block admp drugH1Div" id="F52613069"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Topical: For external use only; avoid contact with eyes. Not recommended for use under occlusive dressings or diaper areas. Discoloration of the skin, hair, and fabrics may occur.</p></div>
<div class="block use drugH1Div" id="F183796"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Dermatological conditions </b>
<b>(topical):</b> Acne urticata; lichen simplex chronicus; contact or atopic dermatitis; endogenous chronic infectious dermatitis; stasis dermatitis; bacterial dermatoses; mycotic dermatoses such as tinea (capitis, cruris, corporis, pedis); impetiginized eczema; nuchal eczema and chronic eczematoid otitis externa; nummular eczema; folliculitis; intertrigo; moniliasis; localized or disseminated neurodermatitis; anogenital pruritus (vulvae, scroti, ani); pyoderma</p></div>
<div class="block cyt drugH1Div" id="F13299529"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F183789"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F10253274"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Information related to the use of iodoquinol in pregnancy is limited and not specific to topical use (Heinonen 1977; Vedder 1956; Verburg 1974)</p></div>
<div class="block brc drugH1Div" id="F10253278"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:0em;display:inline">It is unknown if iodoquinol is present in breast milk. The manufacturer recommends that caution be exercised when administering iodoquinol to breastfeeding women.</p></div>
<div class="block pha drugH1Div" id="F183783"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Amebicide that has antifungal and antibacterial properties.</p></div>
<div class="block phk drugH1Div" id="F183799"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Absorption: There are no data available regarding the percutaneous absorption of iodoquinol.</p></div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-4278011">
<a name="4278011"></a>American Academy of Pediatrics Committee on Drugs. Blindness and neuropathy from diiodohydroxyquin-like drugs. Committee on Drugs. <i>Pediatrics</i>. 1974;54(3):378-379.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/iodoquinol-united-states-and-canada-not-available-drug-information/abstract-text/4278011/pubmed" id="4278011" target="_blank">4278011</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2146587">
<a name="2146587"></a>American Academy of Pediatrics Committee on Drugs. Clioquinol (iodochlorhydroxyquin, vioform) and iodoquinol (diiodohydroxyquin): blindness and neuropathy. <i>Pediatrics</i>. 1990;86(5):797-798.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/iodoquinol-united-states-and-canada-not-available-drug-information/abstract-text/2146587/pubmed" id="2146587" target="_blank">2146587</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>American Academy of Pediatrics Committee on Drugs. "Inactive" ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/iodoquinol-united-states-and-canada-not-available-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Heinonen OP, Sloane D, and Shaprio S, "Birth Defects and Drugs in Pregnancy," Littleton, MA: Publishing Science Group, Inc, 1977.</div>
</li>
<li>
<div class="reference">
                  Quinja (iodoquinol) [prescribing information]. Chicago, IL: Novum Pharma, LLC; February 2018.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19188870">
<a name="19188870"></a>Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/iodoquinol-united-states-and-canada-not-available-drug-information/abstract-text/19188870/pubmed" id="19188870" target="_blank">19188870</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-13295966">
<a name="13295966"></a>Vedder JS, "<i>Acrodermatitis enteropathica</i> (Danbolt-Closs) in Five Siblings; Efficacy of Diodoquin in Its Management," <i>J Pediatr</i>, 1956, 48(2):212-9.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/iodoquinol-united-states-and-canada-not-available-drug-information/abstract-text/13295966/pubmed" id="13295966" target="_blank">13295966</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-4607826">
<a name="4607826"></a>Verburg DJ, Burd LI, Hoxtell EO, et al, "<i>Acrodermatitis enteropathica</i> and Pregnancy," <i>Obstet Gynecol</i>, 1974, 44(2):233-7.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/iodoquinol-united-states-and-canada-not-available-drug-information/abstract-text/4607826/pubmed" id="4607826" target="_blank">4607826</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 8568 Version 130.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
